Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

25 Jul 2013 07:00

RNS Number : 0744K
Halma PLC
25 July 2013
Β 

ο»Ώ

Halma plc

Β 

AGM/Interim Management Statement

Β 

25 July 2013

Β 

Β 

Halma, the leading safety, health and environmental technology group is holding its 119th AGM later today and makes the following Interim Management Statement relating to the period 31 March 2013 to date, with the figures below relating to the first quarter's trading.

Β 

Trading since the start of the financial year has been in line with the Board's expectations.

Β 

Revenue during the first quarter was 13% ahead of last year including 6% organic growth at constant currency. Order intake was 103% of revenue. We continue to increase investment in R&D resources, people development and the expansion of our global footprint to support organic growth.

Β 

Revenue growth was achieved in all major regions, with good organic growth in Mainland Europe and Asia Pacific, the latter supported by a continued strong performance in China. Organic growth rates were lower in the UK and the USA.

Β 

Our Process Safety and Medical sectors performed well whilst Infrastructure Safety has continued to grow steadily.

Β 

Environmental & Analysis has traded in line with expectations. The reorganisation of certain Photonics and Water businesses in this sector is progressing well. This will be completed by the end of 2013 and reorganisation costs will be in line with our previous estimate of Β£1m.

Β 

There have been no material events or transactions during the period impacting the Group's financial position, which remains strong. We continue to identify potential acquisition opportunities which meet our strategic and financial criteria.

Β 

The half yearly results for the period ending 28 September 2013 are expected to be released on 19 November 2013.

Β 

Β 

For further information please contact:

Β 

Halma plc

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

Β 

Β 

Β 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

Β 

Β 

NOTE TO EDITORS

Β 

1.

Halma develops and markets products used worldwide to protect life and improve the quality of life. The Group comprises four business sectors:

Β 

Β·; Process Safety

Products which protect assets and people at work.

Β·; Infrastructure Safety

Products which detect hazards to protect assets and people in public spaces and commercial buildings.

Β 

Β·; Medical

Products used to improve personal and public health.

Β·; Environmental & Analysis

Products and technologies for analysis in safety, life sciences and environmental markets.

Β 

The key characteristics of Halma's businesses are that they are based on specialist technology and application knowledge, offering strong growth potential. Many Group businesses are market leaders in their specialist field.

Β 

2.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma plc, in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

Β 

3.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSZMGZNDDRGFZM
Date   Source Headline
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.